Cargando…
外科手术及利妥昔单抗对原发胃弥漫大B细胞淋巴瘤患者生存的影响
OBJECTIVE: To evaluate the outcome of surgical resection and rituximab for treatment of primary gastric diffuse large B cell lymphoma (PGDLBCL). METHODS: Data of 83 patients with primary gastric diffuse large B cell lymphoma were reviewed retrospectively. 40 patients received surgical resection foll...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364997/ https://www.ncbi.nlm.nih.gov/pubmed/27535862 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.07.012 |
Ejemplares similares
-
利妥昔单抗追加治疗对初次完全缓解的弥漫大B细胞淋巴瘤患者的疗效评估
Publicado: (2016) -
凝血酶原复合物联合小剂量利妥昔单抗治疗血友病B伴抑制物
Publicado: (2017) -
泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤,腿型1例
Publicado: (2023) -
Polatuzumab Vedotin联合利妥昔单抗和苯达莫司汀治疗复发/难治性弥漫大B细胞淋巴瘤的单中心疗效和安全性分析
Publicado: (2022) -
血小板计数检测在成人慢性原发免疫性血小板减少症利妥昔单抗疗效预测中的价值
Publicado: (2018)